Martin M. Okun MD, PhDDermatologist, Fort HealthCare, Fort Atkinson, Wisconsin
Dr. Okun is a board-certified dermatologist practicing medical and surgical dermatology in southeastern Wisconsin. From 2005-2015, he was employed by Abbott Laboratories/AbbVie Inc., where he worked in dermatology medical affairs and clinical development. Dr. Okun was on the teams that successfully developed HUMIRA for treatment of adult psoriasis, pediatric psoriasis (ex-US), and hidradenitis suppurativa (HS). He was instrumental in developing clinical trial designs and novel clinical endpoints for the Phase 2 and 3 HS trials, functioned as a medical monitor for one of the Phase 3 trials, and coauthored the regulatory documents that were used for HS submission to regulatory agencies. Dr. Okun has coauthored more than 20 articles on psoriasis and HS.
DisclosuresDr. Okun is a former employee, current consultant, and member of speakers bureau for AbbVie.
He is a consultant for Azora, Boehringer Ingelheim, Gilead, GlaxoSmithKline, Ichnos, Incyte, InflaRx, Innovaderm, Genentech, Pfizer, Reistone, Seattle Genetics, and UCB.
Recent Contributions to PracticeUpdate:
- Factors Influencing Patient Experience During Incision and Drainage Procedures of Hidradenitis Suppurativa Lesions
- Impact of a Centre-Based Ambulatory Care Concept for Hidradenitis Suppurativa on Disease Activity, Burden, and Patient Satisfaction
- Blood Collection-Based Systemic Inflammation Biomarkers for Patients With Hidradenitis Suppurativa
- Risk of Inflammatory Arthritis After a New Diagnosis of Hidradenitis Suppurativa